Comments on: Pfizer smash market and analyst estimates

By: GSK set to rival Johnson & Johnson for multiple myeloma drug - UK Investor Magazine

Mon, 27 Jan 2020 11:21:05 +0000

[…] Healthcare is majority owned by GSK, with rival firms Pfizer Inc and Shionogi Ltd as a minority […]

By: Faron Pharmaceuticals shares in green on Clevegen trial progress - UK Investor Magazine

Tue, 21 Jan 2020 17:27:05 +0000

[…] Healthcare is majority owned by GSK, with rival firms Pfizer Inc (NYSE: PFE) and Shionogi Ltd (TYO: 4507) as a minority […]

By: Sanofi announces purchase of US based Synthorx - UK Investor Magazine

Sanofi announces purchase of US based Synthorx - UK Investor Magazine — Mon, 09 Dec 2019 14:54:31 +0000

[…] the US, titan Pfizer (NYSE: PFE) have seen their third quarter profits beat market expectations and exceed many analyst reports in an impressive trading […]

By: Open Orphan and hVIVO agree tie-up deal - UK Investor Magazine

Open Orphan and hVIVO agree tie-up deal - UK Investor Magazine — Mon, 09 Dec 2019 12:28:13 +0000

[…] pharmaceutical industry continues to become more saturated and more competitive as the big names continue to dominate […]

By: AorTech shares spike despite modest update - UK Investor Magazine

AorTech shares spike despite modest update - UK Investor Magazine — Fri, 29 Nov 2019 12:31:25 +0000

[…] a positive note, household names such as Pfizer (NYSE: PFE) and GSK (LON: GSK) have smashed both market and analyst expectations, leading to share […]

By: Faron Pharmaceuticals shares soar following US regulatory approval - UK Investor Magazine

Thu, 28 Nov 2019 12:55:36 +0000

[…] leaders such as Pfizer (NYSE: PFE) and GSK (LON: GSK) have reported bullish interim updates, which gives them further foot holding the global pharmaceuticals […]

By: ImmuPharma shares soar following US licence agreement for Lupuzor - UK Investor Magazine

Thu, 28 Nov 2019 10:39:22 +0000

[…] leaders such as Pfizer (NYSE: PFE) and GSK (LON: GSK) have reported bullish interim updates, which gives them further foot holding the global pharmaceuticals […]

By: Udg Healthcare shares dip despite increased operating profit - UK Investor Magazine

Tue, 26 Nov 2019 11:37:52 +0000

[…] leaders such as Pfizer (NYSE: PFE) and GSK (LON: GSK) have reported bullish interim updates, which gives them further foot holding the global pharmaceuticals […]

By: Uniphar announce two new acquisitions - UK Investor Magazine

Uniphar announce two new acquisitions - UK Investor Magazine — Tue, 19 Nov 2019 15:08:56 +0000

[…] and medical industry, there have been updates. Global competitors such as Pfizer (NYSE: PFE) smashed market expectations in their third quarter update.Additionally, GlaxoSmithKine (LON: GSK) another titan in the industry […]

By: Halma shares surge following strong interim update - UK Investor Magazine

Halma shares surge following strong interim update - UK Investor Magazine — Tue, 19 Nov 2019 10:41:51 +0000

[…] In the medical and pharmaceuticals industry, the industry titans continue to dominate. Pfizer (NYSE: PFE) and GSK (LON: GSK) have reported strong quarterly updates. […]

By: Feedback launches Bleepa pilot study - UK Investor Magazine

Feedback launches Bleepa pilot study - UK Investor Magazine — Mon, 18 Nov 2019 14:46:17 +0000

[…] In the medical and pharmaceuticals sector, the big names have continued to dominate headlines. Pfizer (NYSE: PFE) have smashed analyst and market expectations. […]

By: PureTech shares slip after disappointing update - UK Investor Magazine

PureTech shares slip after disappointing update - UK Investor Magazine — Mon, 18 Nov 2019 11:57:35 +0000

[…] In the pharmaceuticals and medical field, big names such as Pfizer (NYSE: PFE) smashed analyst and market expectations. […]

By: Roche acquire US based Promedior - UK Investor Magazine

Roche acquire US based Promedior - UK Investor Magazine — Fri, 15 Nov 2019 14:15:00 +0000

[…] titan Pfizer (NYSE: PFE) smashed market and analyst expectations in their most recent update, whilst GSK (LON: GSK) lifted their annual profit forecast back in […]

By: Concepta shares slide despite new CEO appointment - UK Investor Magazine

Concepta shares slide despite new CEO appointment - UK Investor Magazine — Fri, 15 Nov 2019 12:52:07 +0000

[…] few weeks back it was reported that Pfizer (NYSE: PFE) had smashed market expectations in their most recent update, and British listed GSK (LON: GSK) raised their annual forecast […]

By: AstraZeneca post positive results for Anaemia medication - UK Investor Magazine

AstraZeneca post positive results for Anaemia medication - UK Investor Magazine — Mon, 11 Nov 2019 12:18:22 +0000

[…] medication comes at an important time for AstraZeneca, as competitors such as Pfizer (NYSE: PFE) smashed analyst expectations, and GlaxoSmithKline (LON: GSK) posted a bullish third quarter […]

By: Evgen Pharma shares sink on disappointing new product trial - UK Investor Magazine

Mon, 11 Nov 2019 10:48:46 +0000

[…] tough time in the pharmaceutical industry for Evgen. Global competitors such as Pfizer (NYSE: PFE) smashed market expectations in their third quarter […]

By: Hikma Pharma hold on 2019 guidance - UK Investor Magazine

Hikma Pharma hold on 2019 guidance - UK Investor Magazine — Thu, 07 Nov 2019 11:09:52 +0000

[…] week, global titans such as Pfizer (NYSE: PFE) reported that they had smashed analyst expectations in their third quarter […]

By: Verona Pharma widen third quarter loss - UK Investor Magazine

Verona Pharma widen third quarter loss - UK Investor Magazine — Tue, 05 Nov 2019 12:07:13 +0000

[…] more established names such as Pfizer (NYSE: PFE) have smashed their third quarter, expanding their market dominance. For the nine months to September 30, pretax loss widened to […]

By: GSK raise annual profit forecast - UK Investor Magazine

GSK raise annual profit forecast - UK Investor Magazine — Wed, 30 Oct 2019 14:15:40 +0000

[…] timing of these results boosts GSK, as competitors such as Pfizer (NYSE: PFE) beat market expectations yesterday and LundBeck (CPH: LUN) announced a new digital marketing […]